GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
The company is a medical dictation solution used by medical practitioners
Both parties are expected to invest a total of US $ 1 million to establish the brand
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
The combined entity will have 12 hospitals with 3,666 beds
It plans to double its network to 50 centres across India in the next three years
Subscribe To Our Newsletter & Stay Updated